Risk factors and strategies associated with subcutaneous allergen immunotherapy in children
HDM-SCIT is safe and well-tolerated in children. Key risk factors include age, sex, allergic disease multiplicity, initial treatment dose, and timing. Younger female children with multiple allergic diseases require special attention for potentially severe SRs, emphasizing careful dose management in this demographic.
Authors
- Lanfang Tang (ORCID: https://orcid.org/0000-0002-7994-7066)
- Qin Lü (ORCID: https://orcid.org/0000-0001-8211-6127)
- Na Ling (ORCID: https://orcid.org/0000-0002-0201-5439)
- Jinling Liu (ORCID: https://orcid.org/0000-0002-9989-6550)
Institutions
- Children's Hospital of Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- Respiratory Medicine
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.rmed.2025.108461
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China